Retrospective Study
Copyright ©The Author(s) 2023.
World J Clin Cases. Jan 26, 2023; 11(3): 598-609
Published online Jan 26, 2023. doi: 10.12998/wjcc.v11.i3.598
Table 3 Therapeutic effect and complications of patients in the two groups, n (%)

CDT group (n = 21)
AngioJet group (n = 44)
χ2/t
P values
Thrombus clearance grade
Grade I (< 50%)2 (9.52)4 (9.09)0.2810.922
Grade II (50%-99%)11 (52.38)26 (59.09)
Grade III (100%)8 (38.10)14 (31.82)
Complications
Haemoglobinuria07 (15.91)0.086
Any bleed4 (19.05)00.009
Bacteraemia1 (4.76)00.323
PE after treatment2 (9.52)4 (9.09)1
Left lung2 (9.52)00.101
Embolism of segmental artery2 (9.52)4 (9.09)1
Difference of circumference between affected and unaffected thigh (cm)
Before treatment4.51 ± 0.65c4.76 ± 0.77d-1.2670.21
After treatment1.44 ± 0.36d1.58 ± 0.51d-1.0890.28
Length of stay (d)11.67 ± 5.3410.64 ± 3.522.2150.03
Filter removal
the first phase10 (47.62)15 (34.09)1.0990.294
the cumulative removal17 (80.95)42 (95.45)0.08
IVCF retention time (d)16 (13, 139)59 (12, 231)-0.9910.322
D-dimer after 1 mo (mg/L)0.24 (0.09, 2.15)0.26 (0.09, 2.62)-4.3460